Cronos Group

Toronto, CanadaFounded 2012

Producer & Grower NASDAQ: CRON www.thecronosgroup.com

Share:X / Twitter LinkedIn Suggest a correction

About Cronos Group

Cronos Group is a Toronto-headquartered cannabis company backed by tobacco giant Altria Group, which invested CAD $2.4 billion for a 45% stake. The company focuses on innovative cannabinoid research and product development, with operations in Canada and Israel.

Key Facts

1Altria Group, maker of Marlboro cigarettes, invested CAD $2.4 billion for a 45% stake in 2019
2Invested in Ginkgo Bioworks partnership for fermentation-based cannabinoid production
3Operates through subsidiary Peace Naturals, one of the first licensed producers in Canada
4Holds strategic cannabis operations in Israel through Cronos Israel

Latest News

Cronos Group Pivots Cannabis Strategy Amid Global Market Shifts

7d ago

CRON adapts business model as international cannabis markets mature, signaling strategic realignment for growth opportunities.

View all CRON news

Frequently Asked Questions

Why did Altria invest in Cronos?

Altria, the tobacco giant behind Marlboro, invested in Cronos to gain a foothold in the cannabis industry as a potential growth avenue given declining cigarette sales. The deal gave Cronos significant capital for R&D and expansion.

What is Cronos doing with biosynthesis?

Cronos partnered with Ginkgo Bioworks to develop fermentation-based production of rare cannabinoids, aiming to produce cannabinoids more efficiently than traditional cultivation methods.